fasudil has been researched along with Carotid Arteriopathies, Traumatic in 1 studies
fasudil: intracellular calcium antagonist; structure in first source
fasudil : An isoquinoline substituted by a (1,4-diazepan-1-yl)sulfonyl group at position 5. It is a Rho-kinase inhibitor and its hydrochloride hydrate form is approved for the treatment of cerebral vasospasm and cerebral ischemia.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Fasudil is an inhibitor of protein kinases, including myosin light chain kinase and Rho associated kinase, thereby inhibiting myosin phosphorylation, and it has been clinically used to prevent vasospasm following subarachnoid hemorrage." | 5.30 | The kinase inhibitor fasudil (HA-1077) reduces intimal hyperplasia through inhibiting migration and enhancing cell loss of vascular smooth muscle cells. ( Fukui, R; Hoshiga, M; Ii, M; Ishihara, T; Kohbayashi, E; Nakakoji, T; Negoro, N; Nishiguchi, F; Ohsawa, N; Sasaki, Y; Seto, M; Shibata, N, 1999) |
| "Fasudil is an inhibitor of protein kinases, including myosin light chain kinase and Rho associated kinase, thereby inhibiting myosin phosphorylation, and it has been clinically used to prevent vasospasm following subarachnoid hemorrage." | 1.30 | The kinase inhibitor fasudil (HA-1077) reduces intimal hyperplasia through inhibiting migration and enhancing cell loss of vascular smooth muscle cells. ( Fukui, R; Hoshiga, M; Ii, M; Ishihara, T; Kohbayashi, E; Nakakoji, T; Negoro, N; Nishiguchi, F; Ohsawa, N; Sasaki, Y; Seto, M; Shibata, N, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Negoro, N | 1 |
| Hoshiga, M | 1 |
| Seto, M | 1 |
| Kohbayashi, E | 1 |
| Ii, M | 1 |
| Fukui, R | 1 |
| Shibata, N | 1 |
| Nakakoji, T | 1 |
| Nishiguchi, F | 1 |
| Sasaki, Y | 1 |
| Ishihara, T | 1 |
| Ohsawa, N | 1 |
1 other study available for fasudil and Carotid Arteriopathies, Traumatic
| Article | Year |
|---|---|
The kinase inhibitor fasudil (HA-1077) reduces intimal hyperplasia through inhibiting migration and enhancing cell loss of vascular smooth muscle cells.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Actin Cytoskeleton; Actins; Animals; Aorta; Carotid A | 1999 |